Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease
- 1 May 2005
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 62 (5) , 753-757
- https://doi.org/10.1001/archneur.62.5.753
Abstract
Research from JAMA Neurology — Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease — Preliminary ResultsKeywords
This publication has 10 references indexed in Scilit:
- Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease ProgressionJAMA, 2003
- Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly PeopleArchives of Neurology, 2002
- Statins and the risk of dementiaThe Lancet, 2000
- Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase InhibitorsArchives of Neurology, 2000
- Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC)Published by Springer Nature ,1997
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)Neurology, 1996
- Intraneuronal β-amyloid immunoreactivity in the CNSNeurobiology of Aging, 1996
- Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary CholesterolExperimental Neurology, 1994
- Temporal Sequence of Plaque Formation in the Cerebral Cortex of Non-Demented IndividualsJournal of Neuropathology and Experimental Neurology, 1993
- Pathological verification of ischemic score in differentiation of dementiasAnnals of Neurology, 1980